Graham Capital Management, L.P. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$781,957
-77.2%
28,812
-74.2%
0.02%
-81.8%
Q2 2023$3,436,916
+504.0%
111,806
+608.0%
0.10%
+482.4%
Q1 2023$568,985
-79.7%
15,792
-77.8%
0.02%
-80.0%
Q4 2022$2,808,725
+332.8%
71,071
+340.0%
0.08%
+226.9%
Q3 2022$649,000
-62.5%
16,154
-63.7%
0.03%
-56.7%
Q1 2022$1,732,000
+720.9%
44,459
+736.2%
0.06%
+566.7%
Q4 2021$211,0005,3170.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders